title: Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
abstract: Subcutaneous immunization with purified HSV-1 glycoprotein D (gD) protects susceptible A/J mice against keratitis and encephalitis following corneal HSV-1 challenge. Mice were immunized with gD, in complete Freund's adjuvant, 3.0 micrograms/mouse followed by two booster doses of 1.5 micrograms/mouse at weeks 2 and 4. Control groups of A/J mice were injected with either complete Freund's adjuvant (unimmunized controls) or live HSV-1 MP strain (immunized controls). All mice were challenged ocularly at week 5 with HSV-1, F strain (6.5 x 10(3) PFU) after corneal scarification. None of the 16 animals immunized with gD developed stromal keratitis; only 3 out of 12 animals immunized with live HSV-1 developed a stromal keratitis; 13 out of 16 CFA primed unimmunized mice developed severe stromal keratitis within 14 days post corneal challenge, and 3 out of 16 control CFA primed animals died within 16 days post corneal challenge. At the time of sacrifice (3 weeks post corneal challenge), the ipsilateral trigeminal ganglia were removed and assayed for latent HSV-1 using cocultivation on Vero cell monolayers. The results of these experiments indicate that immunization with gD produces protection against latent ganglionic infection in 56% of the immunized animals, and provides protection against keratitis and death following HSV corneal challenge.
authors.affiliation: Harvard Medical School, Massachusetts Eye and Ear Infirmary, Hilles Immunology Laboratory, Boston.
authors.forename: C S
authors.initials: CS
authors.lastname: Foster
authors.forename: I K
authors.initials: IK
authors.lastname: Sandstrom
authors.forename: P A
authors.initials: PA
authors.lastname: Wells
authors.forename: P
authors.initials: P
authors.lastname: Thompson
authors.forename: J
authors.initials: J
authors.lastname: Daigle
authors.forename: E M
authors.initials: EM
authors.lastname: Opremcak
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002213:Capsid / Q000276:immunology; D003315:Cornea / Q000382:microbiology; D003319:Corneal Stroma / Q000382:microbiology; D004660:Encephalitis / Q000517:prevention & control; D005260:Female; D006023:Glycoproteins / Q000494:pharmacology*; D007635:Keratitis, Dendritic / Q000517:prevention & control*; D051379:Mice; D008805:Mice, Inbred A; D018139:Simplexvirus / Q000276:immunology; D019699:Thrombospondins; D012668:Trigeminal Ganglion / Q000382:microbiology; D014611:Vaccination; D014764:Viral Proteins / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000008:administration & dosage
chemical_list: D000914:Antibodies, Viral; D006023:Glycoproteins; D019699:Thrombospondins; D014764:Viral Proteins; D014765:Viral Vaccines